Results of new drug, ASP8273, show response in patients with treatment-resistant NSCLC
In a second presentation looking at new ways of treating non-small cell lung cancer (NSCLC) that has both the EGFR and T790M mutations, researchers will tell the 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer ...
Nov 20, 2014
0
1